Non‐alcoholic fatty liver disease (NAFLD) is recognized as the most common type of chronic
liver disease in Western countries and the leading cause of cryptogenic cirrhosis. Insulin …

During the past 20 to 30 years, the frequency of patients presenting with nonalcoholic fatty
liver diseases (NAFLD) has increased gradually in Japan in proportion to the increase in the …

Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common
features. Both are associated with visceral obesity, type 2 diabetes mellitus, metabolic …

The combination of hypertension, obesity and non-alcoholic fatty liver disease occurs in
medical practice very often. A number of studies have shown that non-alcoholic fatty liver …

BACKGROUND AND AIM: Insulin resistance is recognized as the pathophysiological
hallmark of non-alcoholic fatty liver disease (NAFLD). A relation between insulin sensitivity …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease both
in the general and pediatric population and has been associated with increased …

Background: Increased uric acid is associated with the metabolic syndrome, conditions
linked to oxidative stress and insulin resistance. Non-alcoholic fatty liver disease (NAFLD) is …

BACKGROUND: Higher levels of white blood cell (WBC) count are known to be associated
with metabolic syndrome and insulin resistance. Nonalcoholic fatty liver disease (NAFLD) is …

The underlying mechanism and pathogenesis of NAFLD remain elusive. Although research
effort has advanced the understanding of the natural history, pathogenesis and …

Nonalcoholic fatty liver disease (NAFLD) has become a major public health issue as its
progression increases risks of multisystem morbidity and mortality. Recent evidence …